Serial 98809285
Live / Registered — Registered (as of 28 Apr 2026)
What this means for you
Registered since 28 Apr 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 28 Apr 2032: the §8 declaration of use).
Record
- Serial number
- 98809285
- Registration number
- 8235236
- Mark type
- Design / logo
- Filed
- 18 Oct 2024
- Published for opposition
- 27 May 2025
- Registered
- 28 Apr 2026
- Next maintenance filing
- §8 declaration of use, due by 28 Apr 2032 (grace period to 28 Oct 2032)
- Attorney of record
- April Wurster
Goods and services
- Class 005 — Pharmaceuticals: therapeutic preparations for neurodegenerative diseases
Owner
- Kenai Therapeutics, Inc., Cambridge, MA, US
- Kenai Therapeutics, Inc., Cambridge, MA, US
- Kenai Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 28 Apr 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Apr 2026 — REGISTERED-PRINCIPAL REGISTER
- 09 Apr 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Apr 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Apr 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Oct 2025 — USE AMENDMENT FILED
- 08 Apr 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Oct 2025 — TEAS STATEMENT OF USE RECEIVED
- 22 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Oct 2025 — SOU EXTENSION 1 GRANTED
- 21 Oct 2025 — SOU EXTENSION 1 FILED
- 21 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 22 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 May 2025 — PUBLISHED FOR OPPOSITION